Skip to main content

Mephedrone: Risk Assessment

Volume 506: debated on Monday 22 February 2010

To ask the Secretary of State for Health what reports he has received of the progress of the European Commission’s risk assessment of mephedrone. (317557)

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has issued a formal request to member states’ National Focal Points for the collection of further information on mephedrone for an EMCDDA-Europol Joint Report due later this year.

The UK’s Advisory Council on the Misuse of Drugs (ACMD) is also conducting a review into the harms associated with mephedrone and other cathinones and has invited the UK National Focal Point to present evidence to this review on behalf of the EMCDDA. The ACMD will incorporate this evidence into its report and will advise Ministers accordingly.